Search - tctmd.com

Displaying 941 - 960 of 3622

Sort: Relevancy | Date

Presentation JIM 2019

Overall Experience of Abluminus DES in Real World and Dedicate Global Clinical Registry

Presenter: Luca Testa

February 14, 2019

Presentation JIM 2019

Cre8™ EVO: Turning PCI challenges of DM patients into today’s solution

Presenter: Didier Carrié

February 14, 2019

Presentation JIM 2019

Unmet Clinical Needs With Current Drug-Eluting Stents

Presenter: Davide Capodanno

February 14, 2019

Presentation

DES vs DCB Revascularization in Patients With Femoropopliteal Arterial Disease

February 11, 2019

Presentation ISET 2019

VIRTUS: Trial Design adn Primary Endpoint Results

Presenter: Robert Lookstein

January 30, 2019

Presentation ISET 2019

5-Year Results from the IN.PACT SFA Randomized Trial

Presenter: Gary Ansel

January 30, 2019

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation ISET 2019

Current Options in the Management of Superficial Arterial Disease in 2019

Presenter: Gary Ansel

January 30, 2019

Presentation LINC 2019

DCB in Severe Calcium: Core-Lab Analysis and Perspectives from the ILLUMINATE Trial

Presenter: D. Chris Metzger

January 25, 2019

Presentation LINC 2019

Insight from AcoArt I5 Year Follow Up

Presenter: Dierk Scheinert

January 25, 2019

Presentation LINC 2019

How I Do It: Deep Vein Thrombectomy

Presenter: Kush R Desai

January 25, 2019

Presentation

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

January 15, 2019

Presentation VIVA 2018

LUTONIX BTK Trial

Presenter: Jihad Mustapha

November 09, 2018

Presentation VIVA 2018

TOBA II 12-Month Data

Presenter: William Gray

November 09, 2018

Presentation VIVA 2018

1-Year Outcomes for Eluvia in Long Lesions

Presenter: William A. Gray

November 09, 2018

Presentation Cardiovascular Interventions 2018

Show me the Data: Key Clinical Trials of 2018

Presenter: Ehtisham Mahmud

October 26, 2018

Presentation Cardiovascular Interventions 2018

So Many Choices – How Do I Choose a Stent in 2018?

Presenter: James Hermiller

October 26, 2018

Presentation TCT Abstracts Posters 2018

Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation

Presenter: Hyungdon Kook

September 25, 2018

Presentation TCT 2018

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Presenter: James B. Hermiller Jr, Hiroki Shiomi

September 25, 2018

Presentation TCT 2018

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Presenter: Felix Mahfoud, Patrick W. Serruys, Pieter C. Smits

September 25, 2018

Advertisement

Overall Experience of Abluminus DES in Real World and Dedicate Global Clinical Registry

Cre8™ EVO: Turning PCI challenges of DM patients into today’s solution

Unmet Clinical Needs With Current Drug-Eluting Stents

DES vs DCB Revascularization in Patients With Femoropopliteal Arterial Disease

VIRTUS: Trial Design adn Primary Endpoint Results

5-Year Results from the IN.PACT SFA Randomized Trial

Drug-Coated Therapy for ISR: Review of Options and Data

Current Options in the Management of Superficial Arterial Disease in 2019

DCB in Severe Calcium: Core-Lab Analysis and Perspectives from the ILLUMINATE Trial

Insight from AcoArt I5 Year Follow Up

How I Do It: Deep Vein Thrombectomy

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

LUTONIX BTK Trial

TOBA II 12-Month Data

1-Year Outcomes for Eluvia in Long Lesions

Show me the Data: Key Clinical Trials of 2018

So Many Choices – How Do I Choose a Stent in 2018?

Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content